Tissue-specific effect of clofibrate on rat lipogenic enzyme gene expression

By Karbowska J.   Kochan Z.   Zelewski L.   Swierczynski J.  

European Journal of Pharmacology, Vol. 370, Iss. 3, 1999-04 ,pp. : 329-336

Elsevier

Access to resources Recommend Favorite

Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases

By Parajuli Nirmal   Ramprasath Tharmarajan   Patel Vaibhav B.   Wang Wang   Putko Brendan   Mori Jun   Oudit Gavin Y.  

Canadian Journal of Physiology and Pharmacology, Vol. 92, Iss. 7, 2014-01 ,pp. : 558-565

NRC Research Press

Access to resources Recommend Favorite

Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin–angiotensin system: a patent review

By Ferreira Anderson J   Bader Michael   Santos Robson AS  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 567-574

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin‐converting enzyme 2–Angiotensin 1‐7/1‐9 system: novel promising targets for heart failure treatment

By  

Fundamental & Clinical Pharmacology, Vol. 32, Iss. 1, 2018-02 ,pp. : 14-25

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat

By Sacco G.   Bigioni M.   Evangelista S.   Goso C.   Manzini S.   Maggi C.A.  

European Journal of Pharmacology, Vol. 414, Iss. 1, 2001-02 ,pp. : 71-78

Elsevier

Access to resources Recommend Favorite